Catriona Hatton
Baker Botts (Brussels)
Managing Partner
Catriona Hatton is the partner in charge of the firm’s Brussels office and co-chair of the firm’s global antitrust and competition law group. She is well known for her work in EU and international merger control, representing clients in some of the largest most complex deals in the market, as well as in antitrust investigations and compliance matters. She advises clients in a number of sectors, including pharmaceuticals, mining, media and entertainment, automotive, chemicals and energy. Catriona is recommended in Chambers Europe (2019) as a business-oriented practitioner. Clients describe her as ‘exceptionally pragmatic and sensitive to the commercial balances that (they) need to achieve, with the ability to communicate in a non-confrontational way’. She is also recommended in Chambers Global, where she is particularly praised for her commercial acumen and her work in international merger control. Catriona was named as a Global Elite Thought Leader by Who’s Who Legal, 2020, listed as a Leading Individual in Antitrust by Legal 500, 2020 and was named ‘Lawyer of the Year’ in EU law (Brussels) by Best Lawyers (2018). Catriona is an Officer of the International Bar Association’s Antitrust Section.
Distinctions
Linked authors
Julie Albert
Baker Botts (New York)
Stuart Blythe
Baker Botts (London)
Michael P. Bodosky
Baker Botts (Washington)
Sean Boland
Baker Botts (Washington)
Mark J. Botti
Baker Botts (Washington)
14436 | Events
Videos
Articles
33310 Bulletin
221
In preparation for the end of the Brexit transition period, the CMA has recently released two consultations inviting comments on proposed updates to its merger control guidance and procedures. On 17 November 2020, the CMA released draft updates to its Merger Assessment Guidelines, which contain (...)
182
This week, the UK Government announced new draft powers under the National Security and Investment Bill (the ‘Bill’) to screen certain deals on national security grounds. The proposals apply to takeovers and investments (including minority share acquisitions) by foreign buyers in a wide range of (...)
294
Recently, the European Commission (“EC”) launched two major public consultations for new legislative tools intended to step up antitrust enforcement in digital and other markets. One consultation relates to a new competition enforcement tool that would allow the EC to pro-actively intervene in (...)
377
In a major judgment handed down on 30 January 2020 in Generics (UK) and Others, the EU Court of Justice (the Court) – the EU’s highest court – clarified for the first time the analytical framework for assessing when patent settlement agreements that restrict a generic pharmaceutical company’s (...)
114
For the first time in 18 years, the European Commission (“Commission”) has imposed interim measures on a company, ordering it to cease and desist certain practices pending the outcome of its antitrust investigation (or for a period of 3 years if the investigation is not concluded earlier). The (...)
75
As counsel involved in negotiating mergers, acquisitions, or other transactions know, provisions that allocate antitrust risk between buyer and seller, or between joint venture (JV) partners, are a common feature of merger and JV agreements. Such provisions are increasingly important in today’s (...)
67
Prior to the year-end holiday season, the United States Government Accountability Office (“GAO”) released the results of its long-awaited study into the prescription drug industry’s “Profits, Research and Development Spending, and Merger and Acquisition Deals.” The report responds to Congressional (...)
53
On 31 March 2017, the German Parliament adopted a reform of the country’s competition act (ARC). Among other amendments, it introduces an additional merger control threshold based on the value of the transaction. This amendment was prompted by a perceived enforcement gap in the current law: (...)
828
On 14 December 2010, the European Commission (the «Commission«) published a set of documents dealing with cooperation between competitors, comprised of guidelines on the applicability of Article 101 of the Treaty on the Functioning of the European Union («TFEU«) (the «EU Guidelines«) and two new (...)
7216
Introduction On 28 May 2007, the Irish Competition Authority announced that it had concluded a settlement agreement with the Irish Medical Organisation (IMO) on 25 May 2007. The settlement concerns an alleged price-fixing by the IMO in relation to the provision of Private Medical Attendant (...)
5104
Introduction On 12 December 2006, the Irish Competition Authority issued revised guidance on merger notification criteria. The new notice modifies the Competition Authority’s 2003 guidance note on the interpretation of certain merger control provisions under the Competition Act 2002. The (...)
3303
Introduction On 25 October 2006, the Irish Competition Authority announced its decision to block the proposed Euro87 million acquisition of Leanort Group by Kingspan Group plc on the grounds that the proposed transaction would substantially lessen competition in the manufacture and provision (...)
6661
Introduction On 3 July 2006, the Irish Competition Authority announced that it had initiated proceedings against the Irish Medical Organisation (IMO) in relation to the IMO’s role in a dispute concerning fees paid by life insurance companies to General Practitioners (GPs) in Ireland. The (...)
5218
Facts On 19 April 2006, the Director of Public Prosecutions for Ireland brought criminal charges against a businessman alleged to have aided members of the IFDA (Irish Ford Dealers Association) in fixing the prices of Ford vehicles on the Irish market. Few details have emerged concerning the (...)
3597
On 8 November 2005, the Irish government announced that it would revoke the much maligned Restrictive Practices (Groceries) Order 1987 (“Groceries Order”) legislation that was enacted to tackle anti-competitive below-cost pricing conducted by large retailers. In its place, the government (...)
Books
Price
€35.00
Women & Antitrust - Voices from the Field, Vol. II
Date
18 November 2020
Price
€35.00
Price
€200.00
Gun Jumping in Merger Control: A Jurisdictional Guide
Date
6 September 2019
Price
€200.00
